Dr. Marcel Nossmann from HiSS Diagnostics GmbH joins ANGLE HQ for two days of product training, enhancing our global team’s expertise and customer support.

We have two new exciting posters at the Biomarkers in Tissue and Blood poster session at EACR 2024 Congress 11:00 to 8:15PM.

Visit us at booth 77 to discuss how we can help enhance your cancer research with specialised circulating tumour cell (CTC) enrichment and analysis.

Anne-Sophie PAILHES-JIMENEZ, our Senior Director, Head of R&D, shared her insights on how CTCs, enriched using Parsortix® technology, can enhance liquid biopsy analysis.

New CellKeep™ poster revealed at New Frontiers in Liquid Biopsies: Data, Technology and Translational Potential on May 13th and 14th on board 034.

From May 15-17 at booth 28, where we will be showcasing our Parsortix® technology and new Portrait®+ CTC staining kit*.

A new agreement with a major global pharmaceutical company to develop a Parsortix® CTC based Androgen Receptor (AR) assay for use in prostate cancer studies.

Visit our booth to learn how we offer a bespoke service with molecular and imaging CTC assays customised to your requirements.

Working in partnership with a major global biopharmaceutical provider, we will be tailoring our existing Parsortix-based DNA damage response (DDR) assay for use in pharmaceutical R&D.

On booth 3054 where we’ll be showcasing our Parsortix® technology and new Portrait®+ CTC staining kits at the San Diego Convention Centre.